Mrtensson, J., Jain, A., & Meister, A
Secure Simple Accessible anytime from any device Access My Patient Portal Availability updates & treatment insights Subscribe for availability updates, announcements, and treatment insights
Later, in 2021, the FDA finally approved the use of semaglutide as an anti-obesity medication
Additionally, evaluations of data from the TriNetX network, a global clinical data repository revealed a significantly increased risk of depression, anxiety, and suicidal behavior in those patients taking GLP-1 Receptor agonists as compared with other medications for diabetes
Hence it has a dual-action impact that may result in more weight loss, according to preliminary research
There is so much more body to get through